Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
chloroxylenol 1 mg + hydrocortison 10 mg + pramoxinhydrochlorid 10 mg dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
clioquinol + hydrocortison + pramoxinhydrochlorid 3 % wt/wt/1 % wt/wt/0,5 % wt/wt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/vol/1 % wt/vol lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/wt/1 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % wt/wt + pramoxinhydrochlorid 1 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
chloroxylenol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
clioquinol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
hydrocortison 1 % + pramocain 1 % skumklysma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pramocaine hydrochloride |
Inferred relationship |
Some |
1 |